A spectrum of BRCA1 and BRCA2 germline deleterious variants in ovarian cancer in Russia-Reference-Cited by-同舟云学术

A spectrum of BRCA1 and BRCA2 germline deleterious variants in ovarian cancer in Russia

Published:2022-11-11 Issue:2 Volume:197 Page:387-395
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Kechin Andrey^ORCID,Boyarskikh Ulyana,Barinov Alexey,Tanas Alexander,Kazakova Svetlana,Zhevlova Anastasia,Khrapov Evgeniy,Subbotin Sergey,Mishukova Olga,Kekeeva Tatiana,Demidova Irina,Filipenko Maxim

Funder

Russian State-funded budget project

Ministry of Science and Higher Education of the Russian Federation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-022-06782-2.pdf

Reference52 articles.

1. Amin N, Chaabouni N, George A (2020) Genetic testing for epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol 65:125–138. https://doi.org/10.1016/J.BPOBGYN.2020.01.005

2. George A, Kaye S, Banerjee S (2017) Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer. Nat Rev Clin Oncol 14:284–296

3. Boussios S, Abson C, Moschetta M et al (2020) Poly (ADP-Ribose) polymerase inhibitors: Talazoparib in ovarian cancer and beyond. Drugs R D 20:55–73. https://doi.org/10.1007/s40268-020-00301-8

4. Santonocito C, Rizza R, Paris I et al (2020) Spectrum of germline BRCA1 and BRCA2 variants identified in 2351 ovarian and breast cancer patients referring to a reference cancer hospital of rome. Cancers (Basel). https://doi.org/10.3390/CANCERS12051286

5. You Y, Li L, Lu J et al (2020) Germline and somatic BRCA1/2 mutations in 172 Chinese women with epithelial ovarian cancer. Front Oncol. https://doi.org/10.3389/FONC.2020.00295

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Untapped Potential of Poly(ADP-Ribose) Polymerase Inhibitors: Lessons Learned From the Real-World Clinical Homologous Recombination Repair Mutation Testing;World Journal of Oncology;2024-08

2. Northern origin of the BRCA2 c.5286 T > G founder allele;Breast Cancer Research and Treatment;2023-12-07

3. Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus;Breast Cancer Research and Treatment;2023-10-18

4. Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru;Frontiers in Oncology;2023-08-17

5. Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus;2023-08-10